FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically, to a peptide immunogenic construct EMPD IgE, and can be used in medicine.
EFFECT: peptide immunogenic EMPD IgE construct with SEQ ID NO: 88-95, 98-124 or 130 can be used for effectively treating an IgE-mediated allergic disease.
3 cl, 21 dwg, 7 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TAU-PEPTIDE IMMUNOGENIC CONSTRUCTS | 2018 |
|
RU2798972C2 |
| IL-31 PEPTIDE IMMUNOGENS AND THEIR COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS | 2018 |
|
RU2799440C2 |
| PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND COMPOSITIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES AFFECTED BY IMPAIRED IL-6 REGULATION | 2019 |
|
RU2780161C1 |
| PEPTIDE IMMUNOGENS FROM C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND COMPOSITIONS BASED ON THEM FOR TREATMENT OF SYNUCLEONOPATHIES | 2018 |
|
RU2810774C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA | 2013 |
|
RU2811687C2 |
| ANTI-IGE ANTIBODIES | 2017 |
|
RU2816207C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| ANTI-BCMA ANTIBODIES CONTAINING ONLY HEAVY CHAIN | 2017 |
|
RU2781301C2 |
